HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MEDTIDE

21.520

+0.8003.86%

Volume:70.60K

Turnover:1.50M

Market Cap:3.05B

PE:11.30

High:22.000

Open:20.700

Low:20.700

Close:20.720

52wk High:33.180

52wk Low:17.640

Shares:141.80M

HK Float Shares:141.80M

Volume Ratio:0.84

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(LYR):1.904

ROE:10.89%

ROA:6.82%

PB:1.60

PE(LYR):11.30

PS:4.74

Loading ...

Overview Company News Filings

Medtide unit CPC Scientific signs USD 22.72 million Rocklin construction contract with Market One Builders

Medtide: No Share Capital Movements in May 2026, Public Float Meets 25% Threshold

Bulletin Express

Precision Peptide issues 300,000 shares at $0.42 to settle $125,000 CEO debt

Precision Peptide signs compounding deal with US 503A sterile pharmacy partner

Precision Peptide expands exclusive revenue-share marketing partnership with MMA.INC

Precision Peptide signs exclusive marketing partnership with Mixed Martial Arts Group Limited

Medtide: April 2026 Monthly Return Confirms Unchanged 141.80 Million H-Share Capital and Adequate Public Float

Bulletin Express

MEDTIDE 2025年营收同比增长28.9%，净利大幅提升并完成上市后资本结构优化

Bulletin Express

Medtide publishes 2025 ESG report

Medtide publishes 2025 annual report

Precision Peptide grants 800,000 stock options to consultants at $0.5 per share

Medtide Doubles Issued Share Capital to 141.80 Million Shares through Conversion of 68.20 Million Unlisted Shares

Bulletin Express

Medtide (SEHK:3880) Net Margin Surge In 1H FY 2025 Tests Earnings Quality Concerns

Simply Wall St.

Medtide 2025 Results: Revenue Reaches RMB570.09 Million, Net Profit Soars 267.3%

Bulletin Express

Medtide Proposes Articles Revision and Scraps Supervisory Committee in Line with New PRC Company Law

Bulletin Express

Medtide proposes bylaw amendments to replace supervisory committee with board audit committee

Medtide Inc - Profit for Year RMB217.4 Mln

THOMSON REUTERS

Medtide FY25 profit jumps to RMB 217 million; revenue rises 28.9% to RMB 570 million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/03880/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"03880","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","market":"HK","secType":"STK","nameCN":"MEDTIDE","latestPrice":21.52,"timestamp":1790755159586,"preClose":20.72,"halted":0,"volume":70600,"delay":0,"changeRate":0.038610038610038644,"floatShares":141800000,"shares":141800000,"eps":1.9043244027772326,"marketStatus":"Not Yet Opened","change":0.8,"latestTime":"09-30 15:59:19","open":20.7,"high":22,"low":20.7,"amount":1504850,"amplitude":0.062741,"askPrice":21.88,"askSize":300,"bidPrice":21.06,"bidSize":400,"shortable":0,"etf":0,"ttmEps":1.3913496454477696,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":0,"adr":0,"listingDate":1751212800000,"exchange":"SEHK","adjPreClose":20.72,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":0.8372865259254526,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","floatShares":141800000,"roa":"6.82%","roe":"10.89%","lyrEps":1.904324,"volumeRatio":0.8372865259254526,"shares":141800000,"dividePrice":0,"high":22,"amplitude":0.062741,"preClose":20.72,"low":20.7,"week52Low":17.64,"pbRate":"1.60","psRate":"4.74","week52High":33.18,"institutionHeld":0,"latestPrice":21.52,"committee":0.142857,"eps":1.9043244027772326,"divideRate":0,"volume":70600,"delay":0,"ttmEps":1.3913496454477696,"open":20.7,"prevYearClose":30.48,"prevWeekClose":22.78,"prevMonthClose":21.52,"prevQuarterClose":21.52,"fiveDayClose":22.6,"twentyDayClose":21.22,"sixtyDayClose":22.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03880\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787794200000,"name":null,"time":"","dateTimestamp":1787760000000,"actualEps":null},{"date":"2026-03-30","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-29","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03880\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03880\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1754409600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03880\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03880","date":"2026-09-30","current":15.466996,"percent":0.380645,"low":11.049775,"twenty":12.660198,"median":29.696692,"eighty":37.085683,"high":89.502411,"avg":31.424369,"sd":21.190558,"marketCap":3051536000},"quantilePoints":[{"date":"2025-06-27","current":64.550519,"twenty":64.550519,"median":64.550519,"eighty":64.550519,"marketCap":4183100000},{"date":"2025-07-04","current":69.032987,"twenty":66.795355,"median":68.595377,"eighty":69.313609,"marketCap":4473790000},{"date":"2025-07-11","current":68.445519,"twenty":67.311524,"median":68.276633,"eighty":68.994281,"marketCap":4431250000},{"date":"2025-07-18","current":76.171108,"twenty":67.389311,"median":68.984604,"eighty":75.214843,"marketCap":4927550000},{"date":"2025-07-25","current":74.03868,"twenty":67.965697,"median":71.906475,"eighty":74.616858,"marketCap":4807020000},{"date":"2025-08-01","current":77.026259,"twenty":68.377965,"median":73.828208,"eighty":76.342138,"marketCap":4970090000},{"date":"2025-08-08","current":73.611635,"twenty":68.565405,"median":73.719922,"eighty":75.214843,"marketCap":4761644000},{"date":"2025-08-15","current":78.991101,"twenty":68.906759,"median":73.83709,"eighty":76.342138,"marketCap":5101964000},{"date":"2025-08-22","current":89.502411,"twenty":69.02331,"median":74.090002,"eighty":78.320217,"marketCap":5762752000},{"date":"2025-08-29","current":78.512395,"twenty":70.155476,"median":74.257083,"eighty":79.74991,"marketCap":5079276000},{"date":"2025-09-05","current":41.646228,"twenty":68.906759,"median":74.188856,"eighty":79.74991,"marketCap":5031064000},{"date":"2025-09-12","current":37.986037,"twenty":67.389311,"median":74.066692,"eighty":79.087699,"marketCap":4597156000},{"date":"2025-09-19","current":35.879032,"twenty":42.439428,"median":73.832649,"eighty":78.741923,"marketCap":4339080000},{"date":"2025-09-26","current":35.972365,"twenty":39.207677,"median":73.603619,"eighty":78.545842,"marketCap":4339080000},{"date":"2025-10-03","current":36.895298,"twenty":38.254613,"median":73.439791,"eighty":78.477782,"marketCap":4461028000},{"date":"2025-10-10","current":35.939087,"twenty":37.926552,"median":73.260895,"eighty":78.387462,"marketCap":4339080000},{"date":"2025-10-17","current":35.261849,"twenty":36.980504,"median":69.008796,"eighty":78.069934,"marketCap":4254000000},{"date":"2025-10-24","current":35.954012,"twenty":36.188249,"median":68.445519,"eighty":77.701013,"marketCap":4339080000},{"date":"2025-10-31","current":35.900465,"twenty":36.021695,"median":67.397498,"eighty":77.513348,"marketCap":4339080000},{"date":"2025-11-07","current":35.922904,"twenty":35.979492,"median":65.840942,"eighty":76.855229,"marketCap":4339080000},{"date":"2025-11-14","current":36.196001,"twenty":35.973277,"median":41.646228,"eighty":76.009632,"marketCap":4384456000},{"date":"2025-11-21","current":32.839875,"twenty":35.967307,"median":40.069862,"eighty":75.286139,"marketCap":3976072000},{"date":"2025-11-28","current":33.374508,"twenty":35.955467,"median":38.580928,"eighty":74.943808,"marketCap":4055480000},{"date":"2025-12-05","current":32.851251,"twenty":35.944759,"median":38.254067,"eighty":74.758171,"marketCap":3998760000},{"date":"2025-12-12","current":33.023157,"twenty":35.900465,"median":37.886895,"eighty":74.473119,"marketCap":4027120000},{"date":"2025-12-19","current":34.430381,"twenty":35.39442,"median":37.394857,"eighty":74.229792,"marketCap":4208624000},{"date":"2025-12-24","current":34.99421,"twenty":35.141853,"median":37.085683,"eighty":74.147921,"marketCap":4290868000},{"date":"2026-01-02","current":33.635992,"twenty":35.029056,"median":36.743987,"eighty":74.11624,"marketCap":4140560000},{"date":"2026-01-09","current":32.725127,"twenty":34.456149,"median":36.454304,"eighty":74.08534,"marketCap":4038464000},{"date":"2026-01-16","current":32.687847,"twenty":33.647972,"median":36.236629,"eighty":74.049885,"marketCap":4046972000},{"date":"2026-01-23","current":31.091299,"twenty":33.318703,"median":36.073206,"eighty":73.917726,"marketCap":3845616000},{"date":"2026-01-30","current":31.269354,"twenty":33.177249,"median":36.016394,"eighty":73.831761,"marketCap":3885320000},{"date":"2026-02-06","current":27.433753,"twenty":32.966335,"median":35.983345,"eighty":73.698264,"marketCap":3417380000},{"date":"2026-02-13","current":29.767101,"twenty":32.846701,"median":35.969241,"eighty":73.606825,"marketCap":3729340000},{"date":"2026-02-20","current":29.696692,"twenty":32.725127,"median":35.967659,"eighty":73.603619,"marketCap":3715160000},{"date":"2026-02-27","current":28.724265,"twenty":32.439619,"median":35.961022,"eighty":73.603001,"marketCap":3632916000},{"date":"2026-03-06","current":25.544273,"twenty":32.105235,"median":35.955322,"eighty":73.439791,"marketCap":3204680000},{"date":"2026-03-13","current":25.719686,"twenty":31.941403,"median":35.950844,"eighty":73.376851,"marketCap":3241548000},{"date":"2026-03-20","current":24.620311,"twenty":31.419436,"median":35.939087,"eighty":73.260895,"marketCap":3091240000},{"date":"2026-03-27","current":25.407751,"twenty":30.961293,"median":35.900465,"eighty":70.436098,"marketCap":3181992000},{"date":"2026-04-02","current":12.694395,"twenty":30.374151,"median":35.877946,"eighty":69.313609,"marketCap":3139452000},{"date":"2026-04-10","current":12.836208,"twenty":29.799581,"median":35.844414,"eighty":69.013634,"marketCap":3199008000},{"date":"2026-04-17","current":12.660198,"twenty":28.991894,"median":35.202659,"eighty":68.828913,"marketCap":3156468000},{"date":"2026-04-24","current":12.397874,"twenty":27.75939,"median":35.115214,"eighty":68.535434,"marketCap":3091240000},{"date":"2026-04-30","current":12.269611,"twenty":26.785787,"median":34.99421,"eighty":68.377965,"marketCap":3060044000},{"date":"2026-05-08","current":12.363155,"twenty":25.983648,"median":34.594549,"eighty":67.965697,"marketCap":3094076000},{"date":"2026-05-15","current":12.534163,"twenty":25.665008,"median":34.175169,"eighty":67.389311,"marketCap":3145124000},{"date":"2026-05-22","current":12.642172,"twenty":25.399381,"median":33.645975,"eighty":67.311524,"marketCap":3164976000},{"date":"2026-05-29","current":12.270986,"twenty":25.218458,"median":33.406025,"eighty":67.131365,"marketCap":3082732000},{"date":"2026-06-05","current":11.125953,"twenty":24.642571,"median":33.30501,"eighty":64.550519,"marketCap":2799132000},{"date":"2026-06-12","current":13.017265,"twenty":13.007169,"median":33.187074,"eighty":42.637728,"marketCap":3272744000},{"date":"2026-06-18","current":12.671021,"twenty":12.943368,"median":33.126975,"eighty":41.844528,"marketCap":3193336000},{"date":"2026-06-26","current":12.518344,"twenty":12.901138,"median":33.023157,"eighty":41.133711,"marketCap":3139452000},{"date":"2026-07-03","current":12.429887,"twenty":12.724861,"median":32.858736,"eighty":40.911062,"marketCap":3119600000},{"date":"2026-07-10","current":13.463401,"twenty":12.685266,"median":32.845563,"eighty":39.914225,"marketCap":3374840000},{"date":"2026-07-17","current":13.021079,"twenty":12.724861,"median":32.687847,"eighty":39.039678,"marketCap":3275580000},{"date":"2026-07-24","current":12.950528,"twenty":12.774507,"median":32.49883,"eighty":38.697228,"marketCap":3258564000},{"date":"2026-07-31","current":12.667228,"twenty":12.718655,"median":32.350921,"eighty":38.507791,"marketCap":3193336000},{"date":"2026-08-07","current":11.576024,"twenty":12.668745,"median":32.105235,"eighty":38.341571,"marketCap":2923916000},{"date":"2026-08-14","current":12.133289,"twenty":12.639428,"median":31.958711,"eighty":38.254613,"marketCap":3068552000},{"date":"2026-08-21","current":13.057601,"twenty":12.633554,"median":31.917498,"eighty":38.145216,"marketCap":3309612000},{"date":"2026-08-28","current":15.462922,"twenty":12.621641,"median":31.567575,"eighty":37.94638,"marketCap":3048700000},{"date":"2026-09-04","current":15.370447,"twenty":12.633554,"median":31.132408,"eighty":37.865542,"marketCap":3031684000},{"date":"2026-09-11","current":13.30358,"twenty":12.639428,"median":30.942991,"eighty":37.772667,"marketCap":2627554000},{"date":"2026-09-18","current":14.784774,"twenty":12.648608,"median":30.467091,"eighty":37.452165,"marketCap":2923916000},{"date":"2026-09-25","current":16.364708,"twenty":12.659036,"median":29.807701,"eighty":37.099262,"marketCap":3230204000},{"date":"2026-09-30","current":15.43076,"twenty":12.660198,"median":29.696692,"eighty":37.085683,"marketCap":3051536000}],"updateTime":1790884075778},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03880\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642313460","title":"Medtide unit CPC Scientific signs USD 22.72 million Rocklin construction contract with Market One Builders","url":"https://stock-news.laohu8.com/highlight/detail?id=2642313460","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642313460?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:39","pubTimestamp":1781008745,"startTime":"0","endTime":"0","summary":"Medtide’s CPC Scientific unit signed construction contracts with Market One Builders for its Rocklin, California manufacturing site.Guaranteed maximum price set at USD 22.72 million under a cost-plus structure with a 3.5% contractor fee.Work starts within seven days of a notice to proceed; substantial completion targeted within 396 calendar days from start.Facility is expected to add up to 300 kg of annual peptide API capacity once completed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL9v6Wt9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122293097","title":"Medtide: No Share Capital Movements in May 2026, Public Float Meets 25% Threshold","url":"https://stock-news.laohu8.com/highlight/detail?id=1122293097","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122293097?lang=en_us&edition=fundamental","pubTime":"2026-06-03 17:05","pubTimestamp":1780477517,"startTime":"0","endTime":"0","summary":"Medtide Inc. (H-share, HKEX: 03880) reported no changes to its share capital structure for the month ended 31 May 2026, according to the company’s monthly return filed on 3 June 2026. • Issued Share...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640171429","title":"Precision Peptide issues 300,000 shares at $0.42 to settle $125,000 CEO debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2640171429","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640171429?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:22","pubTimestamp":1780399330,"startTime":"0","endTime":"0","summary":"The Precision Peptide Company settled USD 125,000 of debt by issuing 300,000 common shares at a deemed price of USD 0.42 each.The debt represented an unpaid cash bonus owed to CEO Pratap Sandhu.The shares carry a statutory hold period of four months plus one day.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Precision Peptide Company Inc. published the original content used to generate this news brief on June 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDLb9933:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917815","title":"Precision Peptide signs compounding deal with US 503A sterile pharmacy partner","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917815","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640917815?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:04","pubTimestamp":1780398295,"startTime":"0","endTime":"0","summary":"The Precision Peptide Company signed a compounding agreement with a U.S.-based 503A sterile compounding pharmacy for prescription peptide fulfillment.Work is expected to start June 1, 2026, with capacity of up to 25,000 prescriptions per day across all U.S. states.Products under the deal will be 100% compounded in the United States, including BPC-157.The partner’s identity was not disclosed.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL5z4dz8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637339033","title":"Precision Peptide expands exclusive revenue-share marketing partnership with MMA.INC","url":"https://stock-news.laohu8.com/highlight/detail?id=2637339033","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637339033?lang=en_us&edition=fundamental","pubTime":"2026-05-21 19:55","pubTimestamp":1779364508,"startTime":"0","endTime":"0","summary":"The Precision Peptide Company expanded details on an exclusive strategic marketing agreement with MMA.INC that gives it exclusive marketing rights across MMA.INC’s global combat sports platform.Net revenue from MMA-sourced customer sales will be split 50/50 for the first 12 months, shifting to a 75/25 split in Precision’s favor for the rest of the term.The agreement includes a 12-month post-termination revenue-sharing tail on sales to MMA-referred customers.Precision will sell U.S.-manufactured, third-party-tested peptide products into MMA.INC’s ecosystem of more than 5 million social followers, about 530,000 user profiles, 75,000 active students, and more than 800 verified gyms.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Preci","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL7lsptf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634216594","title":"Precision Peptide signs exclusive marketing partnership with Mixed Martial Arts Group Limited","url":"https://stock-news.laohu8.com/highlight/detail?id=2634216594","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634216594?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:50","pubTimestamp":1778586616,"startTime":"0","endTime":"0","summary":"Precision Peptide Company entered exclusive strategic marketing agreement with Mixed Martial Arts Group dated May 8, 2026 to market peptide products to MMA subscriber base.Partnership targets MMA digital ecosystem of more than 5 million social media followers, about 530,000 user profiles, over 75,000 active students, more than 800 verified gyms globally.Net revenue from MMA-sourced sales to be split 50%/50% for first 12 months, shifting to 75% for Precision Peptide Company, 25% for MMA from month 13.Either party can terminate with 30 days’ written notice; MMA profit share continues for 12 months on customers referred during term.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Precision Peptide Company Inc. published the original co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL360Km5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160432466","title":"Medtide: April 2026 Monthly Return Confirms Unchanged 141.80 Million H-Share Capital and Adequate Public Float","url":"https://stock-news.laohu8.com/highlight/detail?id=1160432466","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160432466?lang=en_us&edition=fundamental","pubTime":"2026-05-06 17:05","pubTimestamp":1778058300,"startTime":"0","endTime":"0","summary":"Medtide Inc. filed its Monthly Return for the period ended 30 April 2026 with Hong Kong Exchanges and Clearing on 6 May 2026, reporting no movements in either authorised or issued share capital. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168795308","title":"MEDTIDE 2025年营收同比增长28.9%，净利大幅提升并完成上市后资本结构优化","url":"https://stock-news.laohu8.com/highlight/detail?id=1168795308","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168795308?lang=en_us&edition=fundamental","pubTime":"2026-04-23 22:47","pubTimestamp":1776955636,"startTime":"0","endTime":"0","summary":"根据MEDTIDE发布的2025年度香港上市公司年报摘要，报告期内公司整体经营表现显著提升，并顺利完成首次公开募股，推动资本结构与业务布局进一步优化。...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"MEDTIDE 2025年营收同比增长28.9%，净利大幅提升并完成上市后资本结构优化","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629853555","title":"Medtide publishes 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2629853555","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629853555?lang=en_us&edition=fundamental","pubTime":"2026-04-23 22:42","pubTimestamp":1776955350,"startTime":"0","endTime":"0","summary":"Medtide released its first ESG report, outlining 2025 performance across governance, product responsibility, workforce, and environmental management.Scope 1 and Scope 2 greenhouse gas emissions totaled 9,518 tCO2e, with emissions intensity at 0.17 tCO2e per RMB 10,000 of revenue.Air emissions metrics showed particulate matter at 0.22 tonnes, with VOC emissions at 0.67 tonnes.Operational risk indicators included zero product recalls for safety or health reasons, with 0 confirmed corruption cases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 23, 2026, and is solely res","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL8nH79j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629719858","title":"Medtide publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2629719858","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629719858?lang=en_us&edition=fundamental","pubTime":"2026-04-23 22:32","pubTimestamp":1776954764,"startTime":"0","endTime":"0","summary":"Medtide released 2025 annual report, highlighting June 2025 Hong Kong listing as key milestone.Full-year performance set new records, supported by stronger demand across integrated peptide CRDMO services.Commercial-scale peptide API capacity expanded in second half, lifting annual output capability to over 1 metric ton with single-batch runs above 50 kg.Project pipeline ended year with 1,614 ongoing programs, including 9 NCE GLP-1 development projects across 7 customers.US Rocklin site buildout advanced, targeting 300 kg annual capacity to support localized GMP peptide API supply.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the Issuer Information S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL7zvsJg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627297342","title":"Precision Peptide grants 800,000 stock options to consultants at $0.5 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2627297342","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627297342?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:31","pubTimestamp":1776339109,"startTime":"0","endTime":"0","summary":"Precision Peptide Company granted 800,000 stock options to certain consultants under its omnibus long-term incentive plan.Options carry an exercise price of $0.5 per common share.Terms run from one year to three years from grant date.Shares issued on option exercise will be subject to a four-month hold period from grant date.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL5l8fng:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117575956","title":"Medtide Doubles Issued Share Capital to 141.80 Million Shares through Conversion of 68.20 Million Unlisted Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1117575956","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117575956?lang=en_us&edition=fundamental","pubTime":"2026-04-08 18:00","pubTimestamp":1775642459,"startTime":"0","endTime":"0","summary":"Medtide Inc. filed its Monthly Return for Equity Issuer for March 2026, detailing a major capital restructuring that brings all outstanding shares onto The Stock Exchange of Hong Kong (HKEX). Key...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624080539","title":"Medtide (SEHK:3880) Net Margin Surge In 1H FY 2025 Tests Earnings Quality Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2624080539","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624080539?lang=en_us&edition=fundamental","pubTime":"2026-03-31 21:20","pubTimestamp":1774963251,"startTime":"0","endTime":"0","summary":"Medtide (SEHK:3880) has just posted its FY 2025 first half numbers, with revenue of ¥253.8 million and basic EPS of ¥0.82, set against trailing twelve month revenue of ¥570.1 million and EPS of ¥1.63 that sit alongside a reported year over year earnings growth figure of 267.3%. Over recent periods the company has seen revenue move from ¥197.5 million and EPS of ¥0.40 in the first half of FY 2024 to ¥244.8 million and EPS of ¥0.07 in the second half of FY 2024 and then to the latest ¥253.8...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-sehk3880-net-margin-surge-in-1h-fy-2025-tests-earnin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-sehk3880-net-margin-surge-in-1h-fy-2025-tests-earnin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176842672","title":"Medtide 2025 Results: Revenue Reaches RMB570.09 Million, Net Profit Soars 267.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1176842672","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176842672?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:46","pubTimestamp":1774874819,"startTime":"0","endTime":"0","summary":"Medtide Inc. released its audited results for the year ended 31 December 2025. Revenue increased 28.9% year-on-year to RMB570.09 million, driven mainly by strong growth in CDMO services. Net profit...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176147559","title":"Medtide Proposes Articles Revision and Scraps Supervisory Committee in Line with New PRC Company Law","url":"https://stock-news.laohu8.com/highlight/detail?id=1176147559","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176147559?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:46","pubTimestamp":1774874818,"startTime":"0","endTime":"0","summary":"Medtide Inc. (stock short name: MEDTIDE) announced that its Board of Directors resolved on 30 March 2026 to overhaul the company’s governance framework by amending its Articles of Association and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623131044","title":"Medtide proposes bylaw amendments to replace supervisory committee with board audit committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2623131044","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623131044?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:42","pubTimestamp":1774874555,"startTime":"0","endTime":"0","summary":"Medtide set proposed amendments to articles of association for shareholder vote at a forthcoming annual general meeting.Changes would abolish supervisory committee, shifting its functions to board audit committee under revised PRC Company Law effective July 1, 2024.Package also targets stronger shareholder protections, aligning governance rules with updated PRC regulations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL9HRwvH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623912310","title":"Medtide Inc -  Profit for Year RMB217.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2623912310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623912310?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:38","pubTimestamp":1774874282,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nFWN40I0LK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623310914","title":"Medtide FY25 profit jumps to RMB 217 million; revenue rises 28.9% to RMB 570 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623310914","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623310914?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:37","pubTimestamp":1774874272,"startTime":"0","endTime":"0","summary":"Medtide posted profit for the year of RMB 220 million, tripling from a year earlier.Gross margin widened 6.9 percentage points to 63.4%.Listing in June 2025 expanded cash and cash equivalents to RMB 890 million; gearing ratio fell to 12.6%.Capacity expansion in Hangzhou is set to start up in 1Q 2026, lifting total API production capacity to over one metric ton per year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDLCGGyP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":58,"code":"91000000","status":"200"}]}}